News Releases

A $40.5 million grant from the National Institute on Aging will fund the first major Alzheimer’s disease genetics cohort for Asian Americans and Asian Canadians. Penn Medicine researchers will lead the multisite study.

George Jabboure Netto, MD, an internationally recognized physician-scientist specializing in genitourinary pathology and molecular genetic pathology, has been named chair of Pathology and Laboratory Medicine at Penn Medicine.

In a pre-clinical study published in Nature Biomedical Engineering, a team in the Perelman School of Medicine at the University of Pennsylvania abbreviated the process and generated functional CAR T cells with enhanced anti-tumor potency in 24 hours.

While gene mutations can lead to drug resistance, researchers in the Perelman School of Medicine at the University of Pennsylvania have identified an important, non-genetic adaptation that could also drive resistance to targeted therapy in T cell leukemia, a type of blood cell cancer. Their findings were published this month in Molecular Cell.

Researchers have identified a powerful combination of antivirals to treat COVID-19. Combining the drug brequniar with remdesivir or molnupiravir — both approved by the U.S. Food and Drug Administration for emergency use — inhibited the SARS-CoV-2 virus in human respiratory cells and in mice.

Treating obese mice with the cytokine known as TSLP led to significant abdominal fat and weight loss compared to controls, according to new research published Thursday in Science from researchers in the Perelman School of Medicine at the University of Pennsylvania.

The drug diABZI — which activates the body’s innate immune response — was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania.

A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases.